Caribou Biosciences Inc
NASDAQ:CRBU

Watchlist Manager
Caribou Biosciences Inc Logo
Caribou Biosciences Inc
NASDAQ:CRBU
Watchlist
Price: 1.87 USD -1.06% Market Closed
Market Cap: 174.8m USD

Wall Street
Price Targets

CRBU Price Targets Summary
Caribou Biosciences Inc

Wall Street analysts forecast CRBU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRBU is 11.35 USD with a low forecast of 4.04 USD and a high forecast of 33.6 USD.

Lowest
Price Target
4.04 USD
116% Upside
Average
Price Target
11.35 USD
507% Upside
Highest
Price Target
33.6 USD
1 697% Upside
Caribou Biosciences Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
20% Upside
9926
Akeso Inc
47% Upside
NIOX
Niox Group PLC
21% Upside
GLTO
Galecto Inc
17% Upside
2162
KeyMed Biosciences Inc
47% Upside
196170
Alteogen Inc
20% Upside
PRTA
Prothena Corporation PLC
101% Upside
PGEN
Precigen Inc
147% Upside

Revenue
Forecast

Revenue Estimate
Caribou Biosciences Inc

For the last 4 years the compound annual growth rate for Caribou Biosciences Inc's revenue is -5%. The projected CAGR for the next 3 years is 7%.

-5%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Caribou Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Caribou Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRBU's stock price target?
Price Target
11.35 USD

According to Wall Street analysts, the average 1-year price target for CRBU is 11.35 USD with a low forecast of 4.04 USD and a high forecast of 33.6 USD.

What is Caribou Biosciences Inc's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for Caribou Biosciences Inc's revenue is -5%. The projected CAGR for the next 3 years is 7%.

Back to Top